Efficacy and Safety of Apremilast in Psoriasis
NCT06032858
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Apremilast 30mg
Sponsor
Ghurki Trust and Teaching Hospital